This House resolution expresses support for recognizing October 2025 as "National Breast Cancer Awareness Month." The text highlights breast cancer facts and concerns: about 1 case is diagnosed in the United States every 2 minutes; more than 319,000 new cases are expected in 2025 and nearly 42,000 people will die. The resolution cites 5-year relative survival rates of over 99% for cancers found at a localized stage, 87% for regional stage, and 32% for metastatic disease. It notes more than 168,000 women and an unknown number of men are living with metastatic breast cancer, for which the resolution says no cure currently exists. The text describes racial and ethnic differences in outcomes (for example, Black women have nearly 38% higher mortality than White women; breast cancer is the most common cancer and leading cause of cancer death in Hispanic women) and says rates have not declined for American Indian and Alaska Native women. It also notes a rise in diagnoses among women under 50, increasing incidence from 2012 to 2021 (steeper in women under 50), and unique issues facing younger patients such as early menopause and loss of fertility. The resolution calls attention to more than 4,000,000 survivors and urges action on access to timely, affordable screening, diagnosis, treatment, and funding for research.
The resolution is a formal statement of the House's support for recognizing October 2025 as a month to raise awareness of breast cancer. It highlights public health facts and urges attention to screening, treatment access, research funding, and health disparities. No publicly available information about changes to programs, new legal requirements, or direct services is provided in the text.
No publicly available information.
Supporters present the recognition as a way to increase public awareness, encourage research toward a cure, promote early detection and treatment, and draw attention to disparities and the needs of survivors and people living with metastatic disease. The resolution emphasizes the need for timely, affordable health care (including screening, diagnosis, and treatment) and robust funding for cancer research.
No publicly available information.